176 related articles for article (PubMed ID: 12116052)
1. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration.
Giri SN; Wang Q; Xie Y; Lango J; Morin D; Margolin SB; Buckpitt AR
Biopharm Drug Dispos; 2002 Jul; 23(5):203-11. PubMed ID: 12116052
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of intravenous pirfenidone in sheep.
Bruss ML; Stanley SD; Margolin SB; Giri SN
Biopharm Drug Dispos; 2008 Mar; 29(2):119-26. PubMed ID: 18176939
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses.
Braim AE; Macdonald MH; Bruss ML; Stanley SD; Giri JK; Giri SN
Am J Vet Res; 2008 Jul; 69(7):952-60. PubMed ID: 18593250
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C.
Zhang X; Zhang R; Zhao H; Cai H; Gush KA; Kerr RG; Pettit GR; Kraft AS
Cancer Res; 1996 Feb; 56(4):802-8. PubMed ID: 8631017
[TBL] [Abstract][Full Text] [Related]
7. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
Noker PE; Duncan GF; El Dareer SM; Hill DL
Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA
Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of radiolabelled quinlukast in rats.
Syrovatko M; Laznickova A; Laznicek M
J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Smith NF; Hayes A; Nutley BP; Raynaud FI; Workman P
Cancer Chemother Pharmacol; 2004 Dec; 54(6):475-86. PubMed ID: 15526201
[TBL] [Abstract][Full Text] [Related]
14. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile and placental transfer of a single intravenous injection of [(14)C]chlorpyrifos in pregnant rats.
Abdel-Rahman AA; Blumenthal GM; Abou-Donia SA; Ali FA; Abdel-Monem AE; Abou-Donia MB
Arch Toxicol; 2002 Aug; 76(8):452-9. PubMed ID: 12185413
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of novel inhibitors of androgen synthesis after intravenous administration in mice.
Nnane IP; Njar VC; Brodie AM
Cancer Chemother Pharmacol; 2003 Jun; 51(6):519-24. PubMed ID: 12715204
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Walder P; Buchar E; Machková Z; Vrba T; Flegel M; Janků I; Masek K
Immunopharmacol Immunotoxicol; 1991; 13(1-2):101-19. PubMed ID: 1770213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
